Phase IV study of efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS) in combination with cyclosporine microemulsion (CsA-ME) in kidney transplant patients

Trial Profile

Phase IV study of efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS) in combination with cyclosporine microemulsion (CsA-ME) in kidney transplant patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Ciclosporin; Mycophenolate sodium
  • Indications Renal transplant rejection
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms MYFORMS
  • Sponsors Novartis
  • Most Recent Events

    • 03 Nov 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Nov 2009 Actual end date (1 Aug 2006) added as reported by ClinicalTrials.gov.
    • 17 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top